2022
Ensuring rigor in systematic reviews: Part 7, critical appraisal of systematic review quality
Brackett A, Batten J. Ensuring rigor in systematic reviews: Part 7, critical appraisal of systematic review quality. Heart & Lung 2022, 53: 32-35. PMID: 35124337, DOI: 10.1016/j.hrtlng.2022.01.008.Peer-Reviewed Original Research
2021
Ensuring rigor in systematic reviews: Part 6, reporting guidelines
Batten J, Brackett A. Ensuring rigor in systematic reviews: Part 6, reporting guidelines. Heart & Lung 2021, 52: 22-25. PMID: 34823052, DOI: 10.1016/j.hrtlng.2021.11.002.Peer-Reviewed Original ResearchEnsuring Rigor in systematic reviews: Part 5, quality appraisal, data extraction, synthesis
Batten J, Brackett A. Ensuring Rigor in systematic reviews: Part 5, quality appraisal, data extraction, synthesis. Heart & Lung 2021, 50: 615-617. PMID: 34090176, DOI: 10.1016/j.hrtlng.2021.04.002.Peer-Reviewed Original ResearchHumansSystematic Reviews as Topic
2020
Ensuring the rigor in systematic reviews: Part 4, screening the results
Brackett A, Batten J. Ensuring the rigor in systematic reviews: Part 4, screening the results. Heart & Lung 2020, 50: 182-184. PMID: 33249388, DOI: 10.1016/j.hrtlng.2020.11.002.Peer-Reviewed Original ResearchExecutive summary from American Radium Society’s appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastases
Milano MT, Chiang VLS, Soltys SG, Wang TJC, Lo SS, Brackett A, Nagpal S, Chao S, Garg AK, Jabbari S, Halasz LM, Gephart MH, Knisely JPS, Sahgal A, Chang EL. Executive summary from American Radium Society’s appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastases. Neuro-Oncology 2020, 22: 1728-1741. PMID: 32780818, PMCID: PMC7746939, DOI: 10.1093/neuonc/noaa192.Peer-Reviewed Original ResearchMeSH KeywordsBrain NeoplasmsCranial IrradiationHumansRadiosurgeryRadiumSystematic Reviews as TopicUnited StatesConceptsWhole brain radiotherapyAsymptomatic brain metastasesGood performance statusBrain metastasesMultiple brain metastasesAppropriate use criteriaStereotactic radiosurgeryPerformance statusTreatment optionsAmerican Radium Society Appropriate Use CriteriaHippocampal Sparing-Whole Brain RadiotherapySystematic reviewConventional whole brain radiotherapySingle-fraction stereotactic radiosurgeryProgressive extracranial diseasePoor performance statusAppropriate treatment optionsQuality of evidenceBrainstem metastasesExtracranial diseaseConsensus guidelinesOptimal treatmentSystemic optionsNeurocognitive outcomesPatients